May 24, 2014. Jersey City Medical Center has received the Mission: Lifeline® Bronze Receiving Quality Achievement Award for implementing specific quality improvement measures outlined by the American Heart Association (AHA) for the treatment of patients who suffer severe heart attacks.
Each year in the United States, approximately 300,000 people have a STEMI (ST-elevation segment elevation myocardial infarction), caused by a complete blockage of blood flow to the heart that requires timely treatment. To prevent death, it's critical to restore blood flow immediately, either by surgically opening the blocked vessel or by giving clot-busting medication.
The Mission: Lifeline program helps hospitals, emergency medical services and communities improve response times so people who suffer from a STEMI get prompt, appropriate treatment. The program's goal is to streamline systems of care get heart attack patients quickly from the first 9-1-1 call to the hospital for treatment.
"Jersey City Medical Center is dedicated to improving the quality of care for our patients who suffer a heart attack, and the Mission: Lifeline program is helping us accomplish that goal through internationally respected clinical guidelines," said Joseph F. Scott, President and CEO of Jersey City Medical Center. "We are pleased to be recognized for our dedication and achievements in cardiac care."
According to Dr. A. Gray Ellrodt, Chair of the Mission: Lifeline committee, "This award reflects a significant institutional commitment for improving the quality of care for heart attack patients. All too many heart attack patients in the United States still fail to receive appropriate treatment for their life-threatening condition within the recommended timeframes. We must all continue this important work to streamline and coordinate regional systems of care to save lives and prevent complications."
Jersey City Medical Center earned the award by meeting specific criteria and standards of performance for the quick and appropriate treatment of STEMI patients to open the blocked artery. Before patients are discharged, they are started on aggressive risk reduction therapies such as cholesterol-lowering drugs, aspirin, ACE inhibitors and beta-blockers, and they receive smoking cessation counseling if needed. Eligible hospitals must adhere to these measures at a set level for a designated period to receive the awards.
Contact: Howard Matzner/Steven Clark